France’s initial year of mandatory vaccination against highly pathogenic avian influenza (HPAI) in ducks has shown promising results. Since October last year, all farms with over 250 ducks have been required to vaccinate their birds, using approved DIVA vaccines. With a robust surveillance system in place, approximately 61 million ducks have been vaccinated to date. Importantly, vaccination is seen as a complementary measure, not a substitute for essential biosecurity practices. The funding for this campaign was provided by an 85%-15% split between the state and farmers.

The EU and the World Organisation for Animal Health (WOAH) have endorsed vaccination as a valuable addition to traditional HPAI control measures. Still unfortunately some trade barriers were put by third countries.

Results at a Glance:

• Outbreak Reduction:
Only 10 HPAI outbreaks were reported over the year, with just 2 occurring on vaccinated farms. Research suggests that without vaccination, France would likely have faced around 487 outbreaks.
• Cost Savings:
The total cost of the vaccination campaign reached an estimated €105 million for 60 million ducks, including 1.2 million breeding ducks. This expense is significantly lower than the €1.4 billion loss incurred during the HPAI crisis of 2021–2022.

 

Given the success of the first campaign, France has launched a second year of vaccination. The funding structure has shifted slightly, with 60% covered by the state and 40% by farmers.